AEON Shares up on Phase 2 Results
Kort samengevat
Shares of Irvine-based AEON Biopharma Inc. (NYSE: AEON) jumped 9.8% in after-hours trading after reporting positive clinical data for its medication that treats cervical dystonia (CD) and posttraumatic stress disorder. A poster titled, “Efficacy and Safety of ABP-450 (prabotulinumtoxinA) in Adults with Cervical Dystonia: Results From the Open-label Extension of a Phase 2 Trial,” was […]
Verder lezen bij de bron
Bekijk het volledige nieuwsbericht rechtstreeks bij Orange County Business Journal.
Lees het volledige bericht ↗